Delivery Order SPE2DB22D1017-SPE2DB25FG9DJ
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,463.19 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL insulin on May 6, 2025, with completion scheduled for May 7, 2025. This delivery order represents a non-competitive, non-set-aside award under a firm fixed-price contract structure. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $1,275.43 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL), an insulin product used in diabetes management. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $4,938.18 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,309.82 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL, an insulin medication used in diabetes treatment. The award was made on September 4, 2025, with a completion date of September 5, 2025, under a firm fixed-price contract with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a $5,770.97 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL, an insulin medication used in diabetes treatment. The contract was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of NovoLog 100 Unit/mL vials in 10mL quantities, with a ceiling value of $4,832.32 and a firm fixed price structure. This contract is a non-set-aside award and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $6,102.42 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,296.60 for NovoLog 100 Unit/mL vials (10 mL) on August 12, 2025, with completion targeted for August 13, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,749.33 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price delivery order was competitively awarded without set-aside provisions. The contract calls for performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,592.90 for NovoLog 100 Unit/mL vials (10 mL) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The product will be delivered to...